Biblio

Export 1237 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
B. F. Darst, Huo, Z., Jonaitis, E. M., Koscik, R. L., Clark, L. R., Lu, Q., Kremen, W. S., Franz, C. E., Rana, B., Lyons, M. J., Hogan, K. J., Zhao, J., Johnson, S. C., and Engelman, C. D., “Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1041-1054, 2021.
T. Huan, Tran, T., Zheng, J., Sapkota, S., MacDonald, S. W., Camicioli, R., Dixon, R. A., and Li, L., “Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1401-1416, 2018.
M. Sultana, Camicioli, R., Dixon, R. A., Whitehead, S., Pieruccini-Faria, F., Petrotchenko, E., Speechley, M., Borchers, C. H., and Montero-Odasso, M., “A Metabolomics Analysis of a Novel Phenotype of Older Adults at Higher Risk of Dementia.”, J Alzheimers Dis, vol. 99, no. s2, pp. S317-S325, 2024.
J. A. Luchsinger, Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., and Bagiella, E., “Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.”, J Alzheimers Dis, vol. 51, no. 2, pp. 501-14, 2016.
J. M. Campbell, Stephenson, M. D., de Courten, B., Chapman, I., Bellman, S. M., and Aromataris, E., “Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1225-1236, 2018.
S. L. Adams, Benayoun, L., Tilton, K., Chavez, O. R., Himali, J. J., Blusztajn, J. Krzysztof, Seshadri, S., and Delalle, I., “Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 60, no. 1, pp. 43-56, 2017.
S. C. Conner, Benayoun, L., Himali, J. J., Adams, S. L., Yang, Q., DeCarli, C., Blusztajn, J. K., Beiser, A., Seshadri, S., and Delalle, I., “Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.”, J Alzheimers Dis, vol. 68, no. 1, pp. 357-365, 2019.
S. C. Conner, Benayoun, L., Himali, J. J., Adams, S. L., Yang, Q., DeCarli, C., Blusztajn, J. K., Beiser, A., Seshadri, S., and Delalle, I., “Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.”, J Alzheimers Dis, vol. 68, no. 1, pp. 357-365, 2019.
P. R. Manzine, Pelucchi, S., Horst, M. A., Vale, F. A. C., Pavarini, S. C. I., Audano, M., Mitro, N., Di Luca, M., Marcello, E., and Cominetti, M. R., “microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 113-123, 2018.
A. Di Meco and Praticò, D., “MicroRNAs as Therapeutic Targets for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 2, pp. 367-72, 2016.
R. Tortelli, Lozupone, M., Guerra, V., Barulli, M. Rosaria, Imbimbo, B. P., Capozzo, R., Grasso, A., Tursi, M., Di Dio, C., Sardone, R., Giannelli, G., Seripa, D., Misciagna, G., Panza, F., and Logroscino, G., “Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.”, J Alzheimers Dis, vol. 59, no. 1, pp. 121-130, 2017.
I. De Anda-Duran, Kolachalama, V. B., Carmichael, O. T., Hwang, P. H., Fernandez, C., Au, R., Bazzano, L. A., and Libon, D. J., “Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.”, J Alzheimers Dis, vol. 94, no. 1, pp. 101-113, 2023.
L. Fenton, S Han, D., DiGuiseppi, C. G., Fowler, N. R., Hill, L., Johnson, R. L., Peterson, R. A., Knoepke, C. E., Matlock, D. D., Moran, R., Karlawish, J., and Betz, M. E., “Mild Cognitive Impairment is Associated with Poorer Everyday Decision Making.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1607-1615, 2023.
C. LoBue, Kelley, B. J., Hart, J., Helphrey, J., Schaffert, J., C Cullum, M., Peters, M. E., and Douglas, P. M., “Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1491-1496, 2022.
K. Dhana, James, B. D., Agarwal, P., Aggarwal, N. T., Cherian, L. J., Leurgans, S. E., Barnes, L. L., Bennett, D. A., and Schneider, J. A., “MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults.”, J Alzheimers Dis, vol. 83, no. 2, pp. 683-692, 2021.
D. J. Quintana-Hernández, Miró-Barrachina, M. T., Ibáñez-Fernández, I. J., Del Pino, A. Santana-, Quintana-Montesdeoca, M. P., de Vera, B. Rodríguez, Morales-Casanova, D., Pérez-Vieitez, M. Del Carmen, Rodríguez-García, J., and Bravo-Caraduje, N., “Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
D. J. Quintana-Hernández, Miró-Barrachina, M. T., Ibáñez-Fernández, I. J., Del Pino, A. Santana-, Quintana-Montesdeoca, M. P., de Vera, B. Rodríguez, Morales-Casanova, D., Pérez-Vieitez, M. Del Carmen, Rodríguez-García, J., and Bravo-Caraduje, N., “Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
D. J. Quintana-Hernández, Rojas-Hernández, J., Del Pino, A. Santana-, Suárez, C. Céspedes, Silva, M. Pellejero, Miró-Barrachina, M. Teresa, Fernández, I. Ibáñez, López, J. Antonio Es, and Borkel, L. F., “Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 91, no. 1, pp. 471-481, 2023.
M. Ruiz, Arias, A., Sánchez-Llanos, E., Gil, M. Pilar, López-Ortega, R., Dakterzada, F., Purroy, F., and Piñol-Ripoll, G., “Minor Hallucinations in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 543-549, 2018.
I. H. K. Dias, Brown, C. L., Shabir, K., M Polidori, C., and Griffiths, H. R., “miRNA 933 Expression by Endothelial Cells is Increased by 27-Hydroxycholesterol and is More Prevalent in Plasma from Dementia Patients.”, J Alzheimers Dis, vol. 64, no. 3, pp. 1009-1017, 2018.
E. C. Edmonds, Delano-Wood, L., Jak, A. J., Galasko, D. R., Salmon, D. P., and Bondi, M. W., “"Missed" Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria.”, J Alzheimers Dis, vol. 52, no. 2, pp. 685-91, 2016.
L. Guo, Tian, J., and Du, H., “Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1071-1086, 2017.
Q. Yu, Du, F., Douglas, J. T., Yu, H., Yan, S. ShiDu, and Yan, S. Fang, “Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.”, J Alzheimers Dis, vol. 59, no. 1, pp. 223-239, 2017.
Q. Yu, Du, F., Douglas, J. T., Yu, H., Yan, S. ShiDu, and Yan, S. Fang, “Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.”, J Alzheimers Dis, vol. 59, no. 1, pp. 223-239, 2017.
E. Wawrziczny, Berna, G., Ducharme, F., Kergoat, M. - J., Pasquier, F., and Antoine, P., “Modeling the Distress of Spousal Caregivers of People with Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 703-716, 2017.

Pages